Table 1.
Public hospitals N = 10 | Private hospitals N = 11 | |
---|---|---|
Geographical location, urban area | 10 (100%) | 11 (100%) |
Hospital capacity | ||
Less than 100 beds | 3 (30%) | 5 (55.5%) |
Between 100 and 500 beds | 6 (60%) | 6 (54.5%) |
More than 500 beds | 1 (10%) | 0 (0%) |
Presence of stroke care unit | 5 (50%) | 3 (27.3%) |
Access to IV thrombolysis | ||
24/7 access | 5 (50%) | 6 (54.5%) |
Limited to certain hours | 4 (40%) | 0 (0%) |
Limited to patients who can afford it | 0 (0%) | 4 (36.4%) |
Not regularly available | 1 (10%) | 1 (9.1%) |
Never available | 0 (0%) | 0 (0%) |
Availability of EVT | 6 (60%) | 10 (90.9%) |
Access to EVT | ||
24/7 access | 4 (40%) | 3 (27.3%) |
Limited to certain hours | 0 (0%) | 2 (18.2%) |
Limited to patients who can afford it | 2 (20%) | 6 (54.5) |
Not regularly available | 1 (10%) | 0 (0%) |
Never available | 3 (30%) | 0 (0%) |
Access to medical supplies for EVT since requested | ||
Immediately (<5 min) | 0 (0%) | 2 (18.2%) |
Less than an hour | 6 (60%) | 7 (63.6%) |
1–24 h | 2 (20%) | 2 (18.2%) |
More than 24 h | 2 (20%) | 0 (0%) |
Additional out-of-pocket payment compared to IV-tPA | ||
No additional cost compared to IV-tPA | 2 (20%) | 0 (0%) |
Less than USD 1,000 | 0 (0%) | 1 (9.1%) |
USD 1,000–5,000 | 2 (20%) | 1 (9.1%) |
USD 5,001–10,000 | 3 (30%) | 0 (0%) |
USD 10,001–20,000 | 3 (30%) | 6 (54.5%) |
More than USD 20,000 | 0 (0%) | 3 (27.3%) |
Who covers most of the costs for EVT? | ||
Public funding (Local Government) | 1 (10%) | 0 (0%) |
Public funding (National Government) | 3 (30%) | 0 (0%) |
Private insurance | 0 (0%) | 6 (54.5%) |
Patient | 6 (60%) | 5 (45.5%) |
Existence of clinical registry | 6 (60%) | 5 (45.5%) |
IV-tPA, Intravenous tissue plasminogen activator; EVT, endovascular treatment; USD, United States Dollars.